Source: Annual Congress 2010 - Pro/Con debates: 1. To screen or not to screen for cystic fibrosis: is it still the question, 2. Specific immunotherapy for asthma
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. P. Van Bever (Singapore, Singapore). 2-PRO "SIT is efficacious in allergic asthma?". Annual Congress 2010 - Pro/Con debates: 1. To screen or not to screen for cystic fibrosis: is it still the question, 2. Specific immunotherapy for asthma

Member's Comments

No comment yet.

Related content which might interest you: 2-CON "SIT has little if any effect in allergic asthma" Source: Annual Congress 2010 - Pro/Con debates: 1. To screen or not to screen for cystic fibrosis: is it still the question, 2. Specific immunotherapy for asthma Year: 2010 Is montelukast effective in allergic rhinitis in children? Source: Eur Respir J 2006; 28: Suppl. 50, 263s Year: 2006 Is it more than just asthma? Source: Virtual Congress 2020 – Paediatric respiratory diseases Year: 2020 The need for a personal target value for NO in allergic asthma Source: Annual Congress 2010 - Biomarkers of asthma and COPD: recent advances Year: 2010 Rhinophototherapy: a new tool for the treatment of allergic rhinitis? Source: ISSN=ISSN 1810-6838, ISBN=, page=174 Year: 2005 COPD: An outcome of childhood asthma? Source: Annual Congress 2010 - Functional assessment of paediatric lung disease Year: 2010 From atopic dermatitis to asthma what drives the allergic march? Source: Eur Respir J 2003; 22: Suppl. 45, 137s Year: 2003 Allergen avoidance in allergic asthma: the case for Source: Annual Congress 2011 - Pro/Con Debate ""Allergen avoidance in asthma: useful after all or a waste of time and effort? Year: 2011 Respiratory symptoms in the under-fours: asthma or not? Source: Annual Congress 2011 - PG6 Paediatric asthma: state of the art Year: 2011 Allergen avoidance in allergic asthma: the case against Source: Annual Congress 2011 - Pro/Con Debate ""Allergen avoidance in asthma: useful after all or a waste of time and effort? Year: 2011 Can " Beta-blockers" be useful to treat asthma? Source: Annual Congress 2009 - Beta-blockers may now be beneficial in asthma and COPD Year: 2009 Omalizumab is equally effective in persistent allergic oral corticosteroid-dependent asthma whether due to seasonal allergens or to perennial allergens Source: International Congress 2015 – Asthma and lung immunology Year: 2015 2-Conclusion "Paediatric aspects of SIT and other PRO/CON in childhood asthma" Source: Annual Congress 2010 - Pro/Con debates: 1. To screen or not to screen for cystic fibrosis: is it still the question, 2. Specific immunotherapy for asthma Year: 2010 What is COPD? What is asthma? Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 Anti-IgE treatment: An alternative for severe allergic occupational asthma Source: Annual Congress 2012 - Asthma and COPD at work: what are the effects of exposure and risk factors? Year: 2012 The role of omalizumab or rhuMAb-E25 in the treatment of allergic rhinitis Source: Eur Respir J 2004; 24: 330 Year: 2004 Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma Source: Eur Respir J 2002; 20: 73-78 Year: 2002 Should patients with mild asthma be excluded from allergic rhinitis drug trials? Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015